Literature DB >> 6615747

Side effects of labetalol in newborn infants.

D L Woods, A F Malan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6615747     DOI： 10.1111/j.1471-0528.1983.tb09333.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN： 0306-5456


× No keyword cloud information.
  5 in total

Review 1.  The treatment of hypertension in pregnancy. Clinical pharmacokinetic considerations.

Authors:  C Knott
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

2.  Changes in adrenoceptors and monoamine metabolism in neonatal and adult rat brain after postnatal exposure to the antihypertensive labetalol.

Authors:  E B Erdtsieck-Ernste; M G Feenstra; M H Botterblom; J De Barrios; G J Boer
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

3.  Half-life of maternal labetalol in a premature infant.

Authors:  A Haraldsson; W Geven
Journal:  Pharm Weekbl Sci       Date:  1989-12-15

4.  Adverse neonatal effects of maternal labetalol treatment.

Authors:  B N Crooks; S A Deshpande; C Hall; M P Platt; D W Milligan
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-09       Impact factor: 5.747

5.  Disposition of the adrenergic blocker metoprolol and its metabolite OH-metoprolol in maternal plasma, amniotic fluid and capillary blood of the neonate.

Authors:  S Lindeberg; P Lundborg; C G Regårdh; B Sandström
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.